Clinical Trials

143 enrolled 16 charts

Anal Canal Carcinoma, Anus Neoplasms

NCT03138720 2026-04-22

Pre-operative Treatment for Patients With Untreated Pancreatic Cancer

Phase 2 Completed

40 enrolled 22 charts

Resectable Pancreatic Cancer

NCT03210714 2026-04-22

Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial)

CNSGastrointestinalGenitourinaryLymphoidMyeloid

20 enrolled 10 charts

Familial ependymoma, Ependymoma, Glioma, Histiocytosis, Langerhans-Cell, Lymphoma, Non-Hodgkin, Medulloblastoma, Wilms Tumor, Neuroblastoma, Central Nervous System Neoplasms, Hepatoblastoma, Neuroectodermal Tumors, Primitive, Peripheral, Rhabdoid Tumor

NCT03981146 2026-04-22

ANICCA

Phase 2 Completed

35 enrolled 15 charts

Colorectal Neoplasms

NCT04246177 2026-04-22

LEAP-012

Phase 3 Completed

479 enrolled

Phase 1 Active not recruiting

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Hepatocellular

NCT04521686 2026-04-22

Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations

200 enrolled

BreastCNSDermatologicGastrointestinalGenitourinaryHead & NeckSarcoma

Breast Neoplasms, Chondrosarcoma, Colonic Neoplasms, Glioblastoma, Glioma, Melanoma, Prostatic Neoplasms, Thyroid Neoplasms, Central Nervous System Neoplasms, Cholangiocarcinoma

NCT04858334 2026-04-22

APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation

152 enrolled

Pancreatic Acinar Cell Carcinoma

NCT04891289 2026-04-22

Gemcitabine and Oxaliplatin Chemotherapy With or Without a Floxuridine and Dexamethasone Pump in People With Cholangiocarcinoma That Cannot Be Removed With Surgery

164 enrolled

Cholangiocarcinoma

NCT04973007 2026-04-22

Comparison of Contrast Agents in Liver Magnetic Resonance (MR) for the Detection of Hepatic Metastases

Phase 4 Terminated

10 enrolled

Phase NA Active not recruiting

Colorectal Neoplasms

NCT05005117 2026-04-22

Laparoscopic Approach for Emergency Colon Resection

192 enrolled

Emergencies, Colorectal Neoplasms

NCT05414448 2026-04-22

AIDEN

Phase NA Completed

1,726 enrolled

Adenoma, Colorectal Neoplasms

NCT05655949 2026-04-22

Y-90 With Durvalumab/Gem/Cis in Intrahepatic Cholangio

30 enrolled

Bile Duct Neoplasms, Cholangiocarcinoma

NCT05704010 2026-04-22

Videocapsule Endoscopy in Lynch Syndrome

100 enrolled

Colorectal Neoplasms, Hereditary Nonpolyposis, Lynch Syndrome II

NCT06257264 2026-04-22

A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors

BreastGastrointestinalGenitourinaryGynecologicThoracic

258 enrolled

Urinary Bladder Neoplasms, Breast Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Endometrial Neoplasms, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

NCT06423326 2026-04-22

Gemcitabine, Cisplatin and Nab-Paclitaxel as Neoadjuvant Treatment for Patients With Resectable or Borderline Resectable Pancreatic Cancer

36 enrolled

Phase 1 Active not recruiting

Pancreatic Neoplasms

NCT06607185 2026-04-22

A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors

750 enrolled

GastrointestinalGynecologicThoracic

Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Esophageal Neoplasms, Lung Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms, Cholangiocarcinoma

NCT06840886 2026-04-22

A Study of PHST001 in Advanced Solid Tumors

CNSGastrointestinalGynecologic

272 enrolled

Ovarian Neoplasms, Central Nervous System Neoplasms, Endometrial Neoplasms, Cholangiocarcinoma

NCT06893276 2026-04-22

e-Health Psychosocial Stress and Symptom Management (ePSMI) for Pancreatic Cancer Patients

Phase NA Not yet recruiting

60 enrolled

Pancreatic Neoplasms

NCT07020221 2026-04-22

A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors

Phase 1/2 Recruiting

295 enrolled

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Gastrointestinal Neoplasms, Lung Neoplasms, Neoplasm Metastasis, Pancreatic Neoplasms, Colorectal Neoplasms

NCT07085091 2026-04-22

A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors

GastrointestinalHead & NeckThoracic

170 enrolled

Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell Carcinoma, Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Head and Neck Neoplasms, Neoplasm Metastasis, Colorectal Neoplasms

NCT07152821 2026-04-22

BATTMAN

Phase 3 Recruiting

834 enrolled

Colorectal Neoplasms

NCT07198581 2026-04-22

ALLIANCE

174 enrolled

BreastGastrointestinal

Breast Neoplasms, Colorectal Neoplasms

NCT07353684 2026-04-22

Adebrelimab Plus Apatinib Combined With SOX Regimen as Conversion Therapy for Gastric Cancer

49 enrolled

Adebrelimab

NCT07393906 2026-04-22

Colorectal Cancer Prevention Research Study: Eat Right, Screen Right

200 enrolled

GastrointestinalOther solid neoplasm

Colorectal Cancer Prevention

NCT07412613 2026-04-22

Neoadjuvant/Adjuvant AK104 in Microsatellite Instability-high or Mismatch Repair-deficient, Resectable Colon Cancer

Phase 3 Recruiting

386 enrolled

Resectable Colon Cancer

NCT07450859 2026-04-22

A Study of Nuzefatide Pevedotin (BT5528) in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)

39 enrolled

Neoplasm Metastasis, Pancreatic Neoplasms

NCT07521852 2026-04-22

A Phase IIa, Single-arm, Open-label Clinical Study to Evaluate the Efficacy, Safety and PK of CVM-1118 in Combination With Sintilimab and TACE in Participants With Incurable/Non-metastatic HCC

40 enrolled

Phase NA Not yet recruiting

Carcinoma, Hepatocellular, Neoplasms

NCT07543510 2026-04-22

Low-Dose Bevacizumab and Atezolizumab Combined With TACE-HAIC in Unresectable Hepatocellular Carcinoma

38 enrolled

Carcinoma, Hepatocellular

NCT07543744 2026-04-22

A Comparative Study of Pharmacokinetics, Safety, and Immunogenicity of RPH-030 and Vectibix® in Patients With Metastatic Colorectal Cancer With Wild-type RAS as First-line Therapy in Combination With FOLFIRI

180 enrolled

Phase 2 Not yet recruiting

Colorectal Neoplasms

NCT07543783 2026-04-22

Low-dose Bevacizumab Plus Adebrelimab Combined With Transarterial Chemoembolization Followed by TACE-HAIC

38 enrolled

Phase 2 Not yet recruiting

Carcinoma, Hepatocellular

NCT07543848 2026-04-22

A Prospective, Multicenter, Single-Arm Phase II Exploratory Study of Serplulimab Combined With Oncolytic Virus H101, Short-Course Radiotherapy, and XELOX Chemotherapy as Total Neoadjuvant Treatment for Locally Advanced (cT1-3N0M0) Rectal Cancer

20 enrolled

Phase NA Not yet recruiting

Rectal Neoplasms

NCT07544121 2026-04-22

Effect of Babao Dan Capsule Combined With Antiviral Therapy on the Incidence of Hepatocellular Carcinoma in Patients With Hepatitis B-related Cirrhosis

1,034 enrolled

Phase 1 Not yet recruiting

Carcinoma, Hepatocellular, Liver Cirrhosis, Hepatitis B, Chronic

NCT07544589 2026-04-22

A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers

66 enrolled

Adenocarcinoma Of Esophagus, Adenoviridae Infections, Gastrointestinal Neoplasms, Colorectal Neoplasms

NCT07544784 2026-04-22

APSOC

73 enrolled

Phase 1 Not yet recruiting

Colorectal Cancer Liver Metastases (CRLM)

NCT07545122 2026-04-22

CT-202

162 enrolled

BreastGastrointestinal

Colorectal Neoplasms, Triple Negative Breast Neoplasms

NCT07545356 2026-04-22

A Study of KIVU-305 in Participants With Locally Advanced or Metastatic Solid Tumors

Phase 1 Not yet recruiting

76 enrolled

Colorectal Neoplasms

NCT07546565 2026-04-22

UMC-Colprep

74 enrolled

Colonic Neoplasms, Surgical Wound Infection

NCT01692873 2026-04-21

PACAomics

Phase NA Completed

274 enrolled

Pancreatic Neoplasms

NCT02584985 2026-04-21

ETAP

Phase 3 Completed

226 enrolled

Rectal Neoplasms

NCT02600949 2026-04-21

Personalized Peptide Vaccine in Treating Patients With Advanced Pancreatic Cancer or Colorectal Cancer

300 enrolled

Colorectal Neoplasms

NCT02782949 2026-04-21

Curcumin in Preventing Gastric Cancer in Patients With Chronic Atrophic Gastritis or Gastric Intestinal Metaplasia

50 enrolled 10 charts

CNSGastrointestinalGenitourinaryLymphoidMyeloidSarcoma

Gastritis, Atrophic, Stomach Neoplasms

NCT03213678 2026-04-21

Samotolisib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With TSC or PI3K/MTOR Mutations (A Pediatric MATCH Treatment Trial)

Phase 2 Completed

18 enrolled 12 charts

Ependymoma, Glioma, Histiocytosis, Langerhans-Cell, Lymphoma, Non-Hodgkin, Medulloblastoma, Wilms Tumor, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma, Central Nervous System Neoplasms, Hepatoblastoma, Neuroectodermal Tumors, Primitive, Peripheral, Rhabdoid Tumor

NCT03919292 2026-04-21

Neratinib + Valproate in Advanced Solid Tumors, w/Expansion Cohort in Ras-Mutated Ca

Phase 1/2 Recruiting

83 enrolled

Phase NA Active not recruiting

Colonic Neoplasms, Pancreatic Neoplasms, Disease Progression

NCT04544046 2026-04-21

Supportive Oncology Care At Home RCT

300 enrolled

GastrointestinalHead & NeckLymphoid

Head and Neck Neoplasms, Lymphoma, Pancreatic Neoplasms, Rectal Neoplasms

NCT05009069 2026-04-21

A Study of Atezolizumab With or Without Tiragolumab Following Neoadjuvant Chemoradiotherapy in Participants With Locally Advanced Rectal Cancer

58 enrolled

Rectal Neoplasms

NCT05103904 2026-04-21

Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant

Phase 2 Terminated

3 enrolled

Carcinoma, Hepatocellular

NCT05308446 2026-04-21

Testing the Addition of Nivolumab to Standard Treatment for Patients With Metastatic or Unresectable Colorectal Cancer That Have a BRAF Mutation

84 enrolled

Colonic Neoplasms, Rectal Neoplasms

NCT05480384 2026-04-21

Adjuvant Trastuzumab Deruxtecan (Enhertu) & Nivolumab For Patients Who Are Disease Free After Completion of Trimodality Treatment For HER-2+ Cancers of Esophagus & Gastroesophageal Junction

1 enrolled

Adenocarcinoma Of Esophagus, Esophageal Neoplasms

NCT05486572 2026-04-21

PREMIUM

4,700 enrolled